Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Mood and anxiety disorders are among the major causes of disability worldwide. Despite clear need for better therapies, efforts to develop novel drugs have been relatively unsuccessful. One major reason is lack of translation into neuropsychopharmacology of the impressive recent array of knowledge accrued by clinical and preclinical researches on the brain. Here focus is on epigenetics mechanisms, including microRNAs, which seem particularly promising for the identification of new targets for alternative pharmacological approaches. AREAS COVERED: First, the current knowledge about epigenetic mechanisms, including DNA methylation, posttranslational modification of histone proteins, focusing on histone methylation and acetylation, and posttranscriptional modulation of gene expression by microRNAs is described. Then evidence showing involvement of epigenetics and microRNAs in the pathophysiology of mood and anxiety disorders as well as evidence showing that some of the currently employed antidepressants and mood stabilizers also affect epigenetic and microRNA mechanisms are reviewed. Finally current evidence and novel approaches in favor of drugs regulating epigenetic and microRNA mechanisms as potential therapeutics for these disorders are discussed. EXPERT OPINION: Although still in its infancy, research investigating the effects of pharmacological modulation of epigenetic and microRNA mechanisms in neuropsychiatric disorders continues to provide encouraging findings, suggesting new avenues for treatment of mood and anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011 · cited 1×
“The term ‘epigenetics’ refers to long-lasting changes in gene expression that cannot be accounted for by changes in DNA sequence and that can be influenced by the environment [12-14].”
BackgroundGene silencing by microRNAs: contributions of translational repression and mRNA decay
Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339 · cited 2×
“The RISC complex (Figure 4) is involved in at least three different functions: inhibition of translation initiation and/ or elongation, cotranslational protein degradation, premature termination of translation andmRNAdeadenylation (resulting in mRNA degradation) [63,68,69].”
BackgroundA brain-specific microRNA regulates dendritic spine development
Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., & Greenberg, M. E. (2006) · Nature · doi:10.1038/nature04367 · Cited by 1,786
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 5×
“DNMT inhibitors AzaC Cytidine analog DNA methylation [48] AzaD Cytidine analog DNA methylation [48] Zebularine Cytidine analog DNA methylation [34] RG108 Non-nucleoside inhibitor DNA methylation [48] HDAC inhibitors SB Class I and class II HDAC inhibitor Histone acetylation; Histone methylation [35,52-54,120]”
BackgroundMethodInfluentialCost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
HDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644 · cited 1×
“, stress), and pathophysiology of psychiatric disorders, including MD [15-18].”
BackgroundBASKERVILLE, S., & BARTEL, D. P. (2005) · RNA · doi:10.1261/rna.7240905 · Cited by 1,508 · cited 1×
“1 -- 50 kb from each other) that coordinately control target mRNAs, thus regulating pathways of common cellular responses [78].”
BackgroundEpigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · cited 4×
“4 Epigenetics in mood and anxiety disorders Numerous lines of evidence have implicated epigenetic mechanisms in MD and AD [14,16].”
BackgroundInfluentialGene–environment interactions in psychiatry: joining forces with neuroscience
Caspi, A., & Moffitt, T. E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1925 · Cited by 1,300
Lasting epigenetic influence of early-life adversity on the BDNF gene
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.028 · Cited by 1,273 · cited 3×
“, coding exon 9) mRNA levels and increased methylation at BDNF-4 and BDNF-9 exons in prefrontal cortex (PFC) of adult rats exposed to early life maltreatment [34].”
BackgroundMethod
Cited by
The Emerging Field of Neuroepigenetics
Sweatt, J. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.023 · Cited by 324
“A wide variety of non-coding RNAs have either been shown to be or hypothesized to be involved in regulating cell function in the nervous system, including: piRNAs, microRNAs, small interfering RNAs (siRNAs), and small nuclear RNAs (snRNAs) (Sun et al 2013; Tardito et al 2013).”
Peripheral whole blood microRNA alterations in major depression and bipolar disorder
Maffioletti, E., Cattaneo, A., Rosso, G., Maina, G., Maj, C., Gennarelli, M., Tardito, D., & Bocchio-Chiavetto, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.021 · Cited by 181
Self-citationEmerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
Dwivedi, Y. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/ydwivedi · Cited by 169
“Recent evidence suggests that miRNA biogenesis can be regulated at the epigenetic level.(48) For example, inhibitors of DNA methylation and histone deacetylases can affect expression of several miRNAs.”
BackgroundMamdani, M., Williamson, V., McMichael, G. O., Blevins, T., Aliev, F., Adkins, A., Hack, L., Bigdeli, T., D. van der Vaart, A., Web, B. T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137671 · Cited by 73
Thinking small: towards microRNA-based therapeutics for anxiety disorders
Scott, K. A., Hoban, A. E., Clarke, G., Moloney, G. M., Dinan, T. G., & Cryan, J. F. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.997873 · Cited by 52
“In addition to genetic and environmental factors, it is clear that epigenetics, changes in gene expression that are influenced by the environment and that do not change the actual sequence of the DNA, are also involved in susceptibility and resilience to pathological conditions [23,24].”
Backgroundde Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21
Metadata
- Authors
- Tardito, D., Mallei, A., & Popoli, M.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2012-12-19
- Volume
- 22
- Issue
- 2
- Pages
- 217-233
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2072315340
- Cited by
- 35
- References
- 40
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.